Exagamglogene Autotemcel for Severe Sickle Cell Disease
New England Journal of Medicine · 09.05.2024 · 390 (18) · 1649-1662
DOI: 10.1056/nejmoa2309676 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift New England Journal of Medicine, erschienen am 09.05.2024. Verfasst von Haydar Frangoul und 28 weiteren Autor:innen. Beteiligte Einrichtung: From Sarah Cannon Research Institute at the Children's Hospital at TriStar Centennial (H.F.), Nashville, and Bone Marrow Transplantation and Cellular…. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Fetal Hemoglobin, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 527-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Vertex Pharmaceuticals, CRISPR Therapeutics.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From Sarah Cannon Research Institute at the Children's Hospital at TriStar Centennial (H.F.), Nashville, and Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis (A.S.) - both…
ORCID-Profile: Haydar Frangoul, Franco Locatelli, Akshay Sharma, Selim Corbacioglu, Mark C Walters
Förderung
- Vertex Pharmaceuticals
- CRISPR Therapeutics
Zitieren
APA
Frangoul, H., Locatelli, F., Sharma, A., Bhatia, M., Mapara, M., Molinari, L., Wall, D., Liem, R. I., Telfer, P., Shah, A. J., Cavazzana, M., Corbacioglu, S., Rondelli, D., Meisel, R., Dedeken, L., Lobitz, S., de Montalembert, M., Steinberg, M. H., Walters, M. C., …, & CLIMB SCD-121 Study Group (2024). Exagamglogene Autotemcel for Severe Sickle Cell Disease. New England Journal of Medicine, 390(18), 1649-1662. https://doi.org/10.1056/nejmoa2309676
Vancouver
Frangoul H, Locatelli F, Sharma A, Bhatia M, Mapara M, Molinari L, et al. Exagamglogene Autotemcel for Severe Sickle Cell Disease. New England Journal of Medicine. 2024;390(18):1649-1662. doi:10.1056/nejmoa2309676
BibTeX
@article{Frangoul2024,
author = {Frangoul, Haydar and Locatelli, Franco and Sharma, Akshay and Bhatia, Monica and Mapara, Markus and Molinari, Lyndsay and Wall, Donna and Liem, Robert I and Telfer, Paul and Shah, Ami J and Cavazzana, Marina and Corbacioglu, Selim and Rondelli, Damiano and Meisel, Roland and Dedeken, Laurence and Lobitz, Stephan and de Montalembert, Mariane and Steinberg, Martin H and Walters, Mark C and Eckrich, Michael J and Imren, Suzan and Bower, Laura and Simard, Christopher and Zhou, Weiyu and Xuan, Fengjuan and Morrow, Phuong Khanh and Hobbs, William E and Grupp, Stephan A and CLIMB SCD-121 Study Group, CLIMB SCD-121 Study Group},
title = {Exagamglogene Autotemcel for Severe Sickle Cell Disease},
journal = {New England Journal of Medicine},
year = {2024},
volume = {390},
number = {18},
pages = {1649--1662},
doi = {10.1056/nejmoa2309676}
}
EUVIMED